Drug interactions
Tiotropium-olodaterol + Tranylcypromine
Severity: Major
Tiotropium-olodaterol and Tranylcypromine: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Beta2 agonists should be used with great care in patients taking MAO inhibitors because the cardiovascular effects of the agonist may be enhanced. This may cause tachycardia, hypertension and arrhythmia.
What this interaction means in plain words
Tiotropium-olodaterol and Tranylcypromine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Tiotropium-olodaterol belongs to Respiratory; Tranylcypromine belongs to Central Nervous System.
Why it happens
MAO inhibition increases catecholamine levels, potentiating sympathomimetic cardiovascular effects of the beta2 agonist.
What to do
Monitor blood pressure and heart rate closely; consider alternative therapy or avoid combination when possible, particularly during the first weeks of use and for 2 weeks after MAOI discontinuation.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Tiotropium-olodaterol and Tranylcypromine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Tiotropium-olodaterol
Other interactions of Tranylcypromine
- 5-HTP + Tranylcypromine Contraindicated
- Amitriptyline + Tranylcypromine Contraindicated
- Amoxapine + Tranylcypromine Contraindicated
- Atomoxetine + Tranylcypromine Contraindicated
- Benzphetamine + Tranylcypromine Contraindicated
- Brimonidine + Tranylcypromine Contraindicated
Frequently asked questions
Can I take Tiotropium-olodaterol with Tranylcypromine?
MediHelp rates the interaction as major. Tiotropium-olodaterol and Tranylcypromine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Beta2 agonists should be used with great care in patients taking MAO inhibitors because the cardiovascular effects of the agonist may be enhanced. This may cause tachycardia, hypertension and arrhythmia.
How serious is the interaction between Tiotropium-olodaterol and Tranylcypromine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and heart rate closely; consider alternative therapy or avoid combination when possible, particularly during the first weeks of use and for 2 weeks after MAOI discontinuation.
What other medicines interact with Tiotropium-olodaterol?
MediHelp also lists interactions of Tiotropium-olodaterol with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Tiotropium-olodaterol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
